ENTITY
Gilead Sciences

Gilead Sciences (GILD US)

134
Analysis
Health CareUnited States
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
more
Refresh
bullishGilead Sciences
16 Feb 2024 16:00

Gilead Sciences: A Tale Of Continued Growth in Oncology and HIV Sectors! - Major Drivers

Gilead Sciences exhibited a sturdy performance in 2023, driven by a 7% growth in product sales, excluding revenue from Veklury. Significant sales...

Logo
271 Views
Share
bullishGilead Sciences
01 Jan 2024 08:04

Gilead Sciences Inc.: 3 Major Drivers That Can Propel This Pharma Giant Forward! - Financial Forecasts

Gilead Sciences, Inc. delivered an all-around beat in the previous quarter, showcasing a 5% increase in the base business compared to the same...

Logo
137 Views
Share
bullishGilead Sciences
20 Sep 2023 03:00

Gilead Sciences Inc.: The Unstoppable Growth Machine in Virology and Oncology! - Major Drivers

Gilead Sciences Inc. delivered mixed results for the previous quarter, with revenues above the analyst consensus. Total product sales, excluding...

Logo
247 Views
Share
bullishGilead Sciences
25 May 2023 03:19

Gilead Sciences Inc.: The Xinthera Acquisition Strengthens The Oncology Pipeline – Key Drivers

It was a mixed quarter for Gilead Sciences as the company’s revenues were above Wall Street expectations but it missed out on the earnings...

Logo
271 Views
Share
21 Oct 2021 09:21

Stock Ideas Based on Data Mined from Technical Publications - Electro, Radio, & Ultrasound Therapies

The report identifies companies best positioned in Electro, Radiation, and Ultrasound therapeutic technologies. These therapies are a safer...

Logo
231 Views
Share
x